Mechanism of Drug Resistance in Enterococci and Therapeutic Options -A Review
Article Sidebar
-
Mechanism of antibiotic resistance, Multidrug-resistant Enterococci, Therapeutic options
Abstract
Enterococci exhibit an array of ways for constitutional and extrinsic resistance to primary antimicrobial agents available for clinical use. Susceptibility of these agents to β lactams, aminoglycosides or glycopeptides antibiotics or low susceptibility to combination of these agents, monomicrobial or polymicrobial nature of the infection, the involvement of heart valves or other endovascular structures affects therapy of Enterococcal infection. Vancomycin-resistant phenotypes A and B are most prevalent among medically important Enterococci isolates. Due to poor uptake of aminoglycosides, moderate level inherent resistance was reported in Enterococci. Gentamicin and Streptomycin are among the aminoglycoside antibiotics recommended for synergistic combination therapy with a cell wall acting agent. Enterococci isolates display inherent resistance to beta-lactam antibiotics due to less affinity penicillinbinding proteins, class B. Resistance to macrolides, due to erm B genotype and efflux proteins are common in Enterococci. Fluoroquinolone resistance due to genetic changes in chromosomal resistance determining regions has been observed in Enterococci isolates. Despite studies on good invitro action of Daptomycin, Linezolid and Tigecycline on Enterococci, their use may be limited due to shortage of clinical data and emergence of drug resistance. Thus opti- mal therapeutic option for Multidrug-resistant Enterococci infection is based on empirical observation, higher doses and combination therapies. This article reviews the antimicrobial resistance mechanism in Enterococci and available therapeutic options.
Full text article
References
Arias, C. A., Contreras, G. A., Murray, B. E. 2010. Management of multidrug-resistant enterococcal infections. Clinical Microbiology and Infection, 16(6):555–562.
Arias, C. A., Murray, B. E. 2012. The rise of the Enterococcus: beyond vancomycin resistance. Nature Reviews Microbiology, 10(4):266–278.
Arsène, S., Leclercq, R. 2007. Role of a qnr-Like Gene in the Intrinsic Resistance of Enterococcus faecalis to Fluoroquinolones. Antimicrobial Agents and Chemotherapy, 51(9):3254–3258.
Bourgeois-Nicolaos, N., Massias, L., et al. 2007. Dose Dependence of Emergence of Resistance to Linezolid inEnterococcus faecalisIn Vivo. The Journal of Infectious Diseases, 195(10):1480–1488.
Chong, Y. P., et al. 2010. Quinupristin-dalfopristin versus linezolid for the treatment of vancomycin resistant Enterococcus faecium bacteraemia: efficacy and development of resistance. Scandinavian journal of infectious diseases, 42(6-7):491–499.
Chopra, I., Roberts, M. 2001. Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance. Microbiology and Molecular Biology Reviews, 65(2):232–260.
Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E., Courvalin, P. 2007. Modes and Modulations of Antibiotic Resistance Gene Expression. Clinical Microbiology Reviews, 20(1):79–114.
Galimand, M., Schmitt, E., Panvert, M., Desmolaize, B., Douthwaite, S., Mechulam, Y., Courvalin, P. 2011. Intrinsic resistance to aminoglycosides in Enterococcus faecium is conferred by the 16S rRNA m5C1404-specific methyltransferase EfmM. RNA, 17(2):251–262.
Garrido, A. M. 2014. Antimicrobial Resistance in Enterococci. Journal of Infectious Diseases and Therapy, 02(04):1–7.
Hindler, J. A., Wong-Beringer, A., et al. 2015. In Vitro Activity of Daptomycin in Combination with β-Lactams, Gentamicin, Rifampin, and Tigecy- cline against Daptomycin-Nonsusceptible Enterococci. Antimicrobial Agents and Chemotherapy, 59(7):4279–4288.
Hollenbeck, B. L., Rice, L. B. 2012. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence, 3(5):421–569.
Kristich, C. J., Little, J. L. 2012. Mutations in the Subunit of RNA Polymerase Alter Intrinsic Cephalosporin Resistance in Enterococci. Antimicrobial Agents and Chemotherapy, 56(4):2022– 2027.
Kristich, C. J., Rice, L. B., Arias, C. A. 2014. Enterococcal infection-treatment and antibiotic resistance. Enterococci: From commensals to leading causes of drug-resistant infection.
Leavis, H. L., Willems, R. J. L., Top, J., Bonten, M. J. M. 2006. High-Level Ciprofloxacin Resistance from Point Mutations in gyrA and parC Confined to Global Hospital-Adapted Clonal Lineage CC17 of Enterococcus faecium. Journal of Clinical Microbiology, 44(3):1059–1064.
Linden, P. K., et al. 2001. Treatment of Vancomycin Resistant Enterococcus faecium Infections with Quinupristin/Dalfopristin. Clinical Infectious Diseases, 33(11):1816–1823.
López, M., Tenorio, C., Campo, R. D., Zarazaga, M., Torres, C. 2011. Characterization of the Mechanisms of Fluoroquinolone Resistance in Vancomycin-Resistant Enterococci of Different Origins. Journal of Chemotherapy, 23(2):87–91.
Miller, W. R., Munita, J. M., Arias, C. A. 2014. Mechanisms of antibiotic resistance in enterococci. Expert Review of Anti-infective Therapy, 12(10):1221–1236.
Rajan, R., Amirtha, C., Soundaram, K. M. M., Anandi, V. 2017a. A study on High-level aminoglycoside resistant enterococci isolated from urinary tract infection. Int J curr Adv Res, 6(5):3981–3984.
Rajan, R., Amirtha, C., Soundaram, K. M. M., Anandi, V. 2017b. Detection Of Antimicrobial Resistance Among Enterococci Isolates By Vitek System. Int J Pharm Bio, 8(4):179–184.
Rajan, R., Amirtha, C., Soundaram, K. M. M., Anandi, V. 2017c. Phenotypic characterization of Enterococci at a tertiary care centre of South India. Int J Sci Res, 6(4):9–11.
Shantala, G., Nagarathnamma, T. 2015. Antibiotic resistance in Enterococci: A Review. Int J Pharm Bio Sci, 6(4):903–917.
Smith, J. R., Barber, K. E., Raut, A., Aboutaleb, M., Sakoulas, G., Rybak, M. J. 2015. β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. Journal of Antimicrobial Chemotherapy, 70(6):1738–1743.
Sood, S., Malhotra, M., Das, B. K., Kapil, A. 2008. Enterococcal infections & antimicrobial resistance. The Indian Journal of Medical Research, 128(2):111– 121.
Sujatha, S., Praharaj, I. 2012. Glycopeptide Resistance in Gram-Positive Cocci: A Review. Interdisciplinary Perspectives on Infectious Diseases, pages 1–10.
Werner, G., Fleige, C., et al. 2010. High-level ciprofloxacin resistance among hospital-adapted Enterococcus faecium (CC17). International Journal of Antimicrobial Agents, 35(2):119–125.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.